1. Home
  2. ITCI vs HLNE Comparison

ITCI vs HLNE Comparison

Compare ITCI & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • HLNE
  • Stock Information
  • Founded
  • ITCI 2002
  • HLNE 1991
  • Country
  • ITCI United States
  • HLNE United States
  • Employees
  • ITCI N/A
  • HLNE N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • HLNE Investment Managers
  • Sector
  • ITCI Health Care
  • HLNE Finance
  • Exchange
  • ITCI Nasdaq
  • HLNE Nasdaq
  • Market Cap
  • ITCI 8.0B
  • HLNE 7.6B
  • IPO Year
  • ITCI N/A
  • HLNE 2017
  • Fundamental
  • Price
  • ITCI $86.00
  • HLNE $154.00
  • Analyst Decision
  • ITCI Strong Buy
  • HLNE Hold
  • Analyst Count
  • ITCI 12
  • HLNE 9
  • Target Price
  • ITCI $97.67
  • HLNE $160.50
  • AVG Volume (30 Days)
  • ITCI 455.4K
  • HLNE 564.3K
  • Earning Date
  • ITCI 02-20-2025
  • HLNE 02-04-2025
  • Dividend Yield
  • ITCI N/A
  • HLNE 1.24%
  • EPS Growth
  • ITCI N/A
  • HLNE 51.92
  • EPS
  • ITCI N/A
  • HLNE 4.63
  • Revenue
  • ITCI $613,728,000.00
  • HLNE $648,658,000.00
  • Revenue This Year
  • ITCI $48.41
  • HLNE $23.71
  • Revenue Next Year
  • ITCI $38.26
  • HLNE $8.88
  • P/E Ratio
  • ITCI N/A
  • HLNE $33.27
  • Revenue Growth
  • ITCI 46.08
  • HLNE 31.90
  • 52 Week Low
  • ITCI $62.78
  • HLNE $103.42
  • 52 Week High
  • ITCI $93.45
  • HLNE $203.72
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 54.91
  • HLNE 25.62
  • Support Level
  • ITCI $82.76
  • HLNE $148.65
  • Resistance Level
  • ITCI $89.12
  • HLNE $196.95
  • Average True Range (ATR)
  • ITCI 2.48
  • HLNE 5.39
  • MACD
  • ITCI -0.04
  • HLNE -2.46
  • Stochastic Oscillator
  • ITCI 59.75
  • HLNE 14.35

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.

Share on Social Networks: